Alliqua BioMedical, Inc. is developing a suite of advanced wound care solutions that will enable surgeons, clinicians, and wound care practitioners to address the entire spectrum of challenges presented by chronic and advanced wounds. Alliqua is building this portfolio through its proprietary hydrogel technology platform, targeted acquisitions, and through licensing and distribution agreements with strategic partners that include sorbion GmbH & Co. KG and Celgene Cellular Therapeutics, a subsidiary of Celgene Corporation. Alliqua's contract manufacturing business unit provides custom hydrogels to the OEM market. The Company is headquartered in Langhorne, PA.
Morrisville, US
Size (employees)
87 (est)
Alliqua is headquartered in Morrisville, US

Key People at Alliqua

David Johnson

David Johnson

CEO, and Member of the Board of Directors
Brad C. Barton

Brad C. Barton

Phillip Forman

Phillip Forman

Executive VP Clinical Affairs

Alliqua Office Locations

Alliqua has an office in Morrisville
Morrisville, US (HQ)
200 1010 Stony Hill Rd

Alliqua Data and Metrics

Alliqua Financial Metrics

Alliqua's revenue was reported to be $18.2 m in FY, 2016 which is a 21% increase from the previous period.

Revenue (FY, 2016)

18.2 m

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

11.6 m

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

(28.2 m)

EBIT (FY, 2016)

(31.2 m)

Market capitalization (20-Jul-2017)

17 m

Closing share price (20-Jul-2017)


Cash (31-Dec-2016)

5.6 m
Alliqua's current market capitalization is $17 m.
USDFY, 2013FY, 2014FY, 2015FY, 2016


1.8 m4.8 m15 m18.2 m

Revenue growth, %


Cost of goods sold

2.1 m3.3 m6 m6.7 m

Gross profit

(299.3 k)1.5 m9 m11.6 m

Gross profit Margin, %


R&D expense

63.2 k715.1 k859 k

General and administrative expense

11.7 m26.2 m35.2 m37.1 m

Operating expense total

19.8 m26.9 m37.3 m42.8 m


(20.1 m)(25.4 m)(28.3 m)(31.2 m)

EBIT margin, %


Interest expense

4.8 k3841.6 m2.5 m

Interest income

2.9 k30.7 k41.7 k42 k

Pre tax profit

(25.4 m)(27.7 m)(33.1 m)

Income tax expense

(9 k)14 k(1.7 m)(715 k)

Net Income

(22 m)(25.4 m)(26 m)(28.2 m)
USDFY, 2013FY, 2014FY, 2015FY, 2016


12.1 m16.8 m26.1 m5.6 m

Accounts Receivable

156.8 k968.6 k2.5 m2.8 m


88.4 k477.8 k942 k2.7 m

Current Assets

12.8 m19.6 m32.7 m11.8 m


426 k4.1 m21.2 m

Total Assets

17.5 m29.7 m89.8 m54.5 m

Accounts Payable

746.6 k1.8 m2.6 m2.6 m

Current Liabilities

3.4 m4.1 m11.8 m20.1 m

Total Liabilities

22.4 m

Additional Paid-in Capital

58.5 m92.5 m148.5 m156.4 m

Retained Earnings

(44.6 m)(70 m)(96.1 m)(124.3 m)

Total Equity

14 m22.5 m52.4 m32.1 m

Financial Leverage

1.3 x1.3 x1.7 x1.7 x
USDFY, 2013FY, 2014FY, 2015FY, 2016

Net Income

(22 m)(25.4 m)(26 m)(28.2 m)

Depreciation and Amortization

674.2 k2.9 m4.2 m

Accounts Receivable

(48 k)968.6 k(779.5 k)(281 k)


105.3 k477.8 k(257.3 k)(113 k)

Accounts Payable

174 k1.8 m571.6 k(26 k)

Cash From Operating Activities

(4.8 m)4.7 m(21.6 m)(18.3 m)

Purchases of PP&E

(51.4 k)

Cash From Investing Activities

(118.1 k)(15.4 m)2.2 m

Long-term Borrowings

(1.7 m)

Cash From Financing Activities

16.7 m46.3 m(4.4 m)

Interest Paid

4.8 k999.8 k1.6 m
Y, 2016

Financial Leverage

1.7 x

Alliqua Market Value History

Alliqua Online and Social Media Presence

Alliqua News and Updates

Alliqua Company Life and Culture

You may also be interested in